We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MAPS:NASDAQWM Technology, Inc. Analysis

Data as of 2026-04-16 - not real-time

$0.39

Latest Price

8/10Risk

Risk Level: High

Executive Summary

WM Technology, Inc. (MAPS) is trading at roughly $0.39, dramatically below its DCF‑derived fair value of about $1.89, implying an upside of over 500% if the model holds. The stock is deeply oversold with an RSI of 27 and sits beneath its 20‑day, 50‑day and 200‑day moving averages, while the MACD remains in a bearish configuration, suggesting further short‑term downside pressure despite the support around $0.33. Revenue has fallen 9.7% YoY to $174.7 M and the average paying client base slipped 2% year‑over‑year, driven by pricing pressure in key markets such as California, Michigan and Oklahoma. Operating expenses rose modestly (2% YoY) and profit margins are thin at just over 1%, though gross margins remain exceptionally high at 95% and cash on hand ($62 M) comfortably exceeds debt ($26.5 M). Volatility is extreme (174% 30‑day) and the stock has experienced a 72% drawdown from its peak, underscoring significant price risk.
Despite these headwinds, MAPS trades at a forward PE of ~2.3, a price‑to‑book of 0.74 and a price‑to‑sales of 0.39, all well below the industry averages, indicating a strong value case. The balance sheet is solid with low leverage (debt‑to‑equity ~20%) and ample liquidity, and the company’s high‑margin SaaS platform offers a defensible recurring‑revenue model. However, the cannabis sector remains subject to high regulatory scrutiny and market‑specific pricing pressures, which could delay a revenue turnaround. Investors should weigh the massive valuation upside against the near‑term earnings weakness and sector risk when forming a position.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Oversold technical indicators (RSI 27, price below all SMAs)
  • Revenue contraction and thin profit margin
  • High short‑term volatility and proximity to support level

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Substantial valuation upside relative to DCF and peers
  • Strong cash position and low leverage
  • Uncertainty around client spend recovery and regulatory environment

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Large upside potential if DCF assumptions materialize
  • High gross margins and scalable SaaS business model
  • Improving industry fundamentals as cannabis markets mature

Key Metrics & Analysis

Financial Health

Revenue Growth-9.70%
Profit Margin1.12%
P/E Ratio19.3
ROE2.59%
ROA5.46%
Debt/Equity20.15
P/B Ratio0.7
Op. Cash Flow$26.2M
Free Cash Flow$21.5M
Industry P/E35.7

Technical Analysis

TrendBearish
RSI27.0
Support$0.33
Resistance$0.73
MA 20$0.57
MA 50$0.65
MA 200$0.91
MACDBearish
VolumeIncreasing
Fear & Greed Index88.98

Valuation

Fair Value$1.89
Target Price$2.61
Upside/Downside574.59%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.65
Volatility174.43%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.